Τρέχουσες Μελέτες

HeCOG

CLINICAL STUDIES

  1. HE1/17 – PAVE: Phased Avelumab combined with chemotherapy as first-line treatment for patients with advanced small-cell lung cancer (SCLC) (Completed)
  2. HE2SN/21 – CLIMEDIN : CLinical and MolEcular study with DIgital support of patients with inoperable luNg cancer. (Completed)
  3. HE2_TR/22 – EXPLORE: Whole exome and transcriptome sequencing analysis for the identification of prognostic biomarkers in patients with non-small cell lung cancer. (Active, recruiting)
  4. INNOVATE/1221/0002: New Minimal Residual Disease Detection Liquid Biopsy Test (Active, recruiting)
  5.  Mutographs of cancer: discovering the causes of cancer through mutational signatures (Active, recruiting)
  6. IMPORTANT: IMPlementing geriatric assessment for dose Optimization of CDK4/6 inhibitors in older bReasT cAncer patieNTs (Active, recruiting)